Call to arrange a consultation
+1 416 777 0888

Cases

Action under the new Patented Medicines (Notice of Compliance) Regulations relating to Patent No. 2,402,894 (saxagliptin)

Interlocutory appeal in an action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,547,113, 2,823,159, 2,624,310 and 2,396,561 (rivaroxaban)

Appeal in an action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,547,113, 2,823,159, 2,624,310 and 2,396,561 (rivaroxaban)

Appeal of a trademark expungement case regarding Registration Nos. TMDA22577 and UCA44562 (HORLICKS)

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,791,171 (apixaban)

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,461,202 (apixaban)

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,344,318 and 2,743,326 (daptomycin)

Patent infringement regarding Patent No. 2,743,326 (daptomycin)

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,762,013 and 2,620,380 (pirfenidone)

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,937,365 (pirfenidone)

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,620,380 (pirfenidone)

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,631,646 (pirfenidone)

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,667,654 (pirfenidone)

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,709,997 (pirfenidone)

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,710,014 (pirfenidone)

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,710,358 (pirfenidone)

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,819,967 (pirfenidone)

Interlocutory appeal in a patent impeachment action relating to Patent No. 2,261,630 (infliximab)

Trademark opposition case regarding Registration No. 1,691,811 (INSTA-LOC)

CIRA domain name dispute relating to the domain name STRIPMEISTER.CA

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,507,002 and 2,496,780 (silodosin)

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,823,159, 2,634,310 and 2,547,113 (rivaroxaban)

Action under the Trademarks Act and the Competition Act regarding Registration Nos. TMA580,557 (ENERGIZER MAX), TMA157,162 (ENERGIZER) and TMA740,338 (ENERGIZER)

Motion/Application under the new Patented Medicines (Notice of Compliance) Regulations

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,540,547, 2,596,133, 2,376,596 and 2,407,556 (trastuzumab)

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,540,547, 2,596,133, 2,376,596 and 2,407,556 (trastuzumab)

Interlocutory appeal in a patent impeachment action regarding Patent No. 2,261,630 (infliximab)

Appeal in a patent impeachment case regarding Patent No. 2,261,630 (infliximab)

Statutory appeal in a patent impeachment case regarding Patent No. 2,261,630 (infliximab)

Interlocutory appeal in a patent impeachment action regarding Patent No. 2,261,630 (infliximab)

Interlocutory appeal in a patent impeachment action regarding Patent No. 2,261,630 (infliximab)

Trademark infringement action against the owner of a s. 9 mark

Trademark expungement regarding Registration Nos. TMDA22577 and UCA44562 (HORLICKS)

Application under the old Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,477,301, 2,688,709, 2,476,983, 2,688,694, 2,537,092, 2,687,927, 2,688,695, 2,741,575, 2,688,708, 2,687,924 and 2,741,412 (lenalidomide)

Trademark expungement regarding Registration No. TMA400474 (RED BARN)

Application under the old Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,415,403 (acetaminophen)

Application under the old Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,705,733 (acetaminophen)

Patent infringement case regarding Patent No. 2,407,556 (trastuzumab)

Patent impeachment case regarding Patent No. 2,540,547 (trastuzumab)

Patent impeachment case regarding Patent No. 2,329,829 (trastuzumab)

Patent impeachment case regarding Patent No. 2,376,596 (trastuzumab)

Patent impeachment case regarding Patent No. 2,596,133 (pertuzumab)

Patent infringement case regarding Patent No. 2,787,952 (bevacizumab) with counterclaim for infringement under the new Patented Medicines (Notice of Compliance) Regulations

Interlocutory decision in a trademark infringement action

Application under the old Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,366,785 and 2,476,934 (etanercept)

Appeal in a patent impeachment case regarding Patent No. 2,261,630 (infliximab)

Interlocutory appeal in a patent impeachment case regarding Patent No. 2,261,630 (infliximab)

Interlocutory appeal in a patent impeachment case regarding Patent No. 2,261,630 (infliximab)

Application under s. 18.1 of the old Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,586,023 (sevelamer)

Patent infringement case regarding Patent No. 2,677,529 (Mobile Airborne Contaminant Control Chamber)

Patent infringement case regarding Patent Nos. 2,475,076 and 2,522,321 (Hard Wood Floor Panels and Manufacturing)

Action under the Trademarks Act and the Competition Act regarding Registration Nos. TMA580,557 (ENERGIZER MAX), 157,162 (ENERGIZER) and 740,338 (ENERGIZER)

Interlocutory appeal in a patent impeachment case regarding Patent No. 2,261,630 (infliximab)

Application under the old Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,261,630 (Infliximab).

Application under the old Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,166,483, 2,186,037, 1,338,377, 2,133762, 2,170,647, 2,290,963, 2,346,988, 2,166,794, 2,139,653, 2,180,535, 2,290,531, 2,226,184 and 2,193,994 (esomeprazole)

Trademark infringement case regarding Registration No. TMA396,079 (FREEDOMWALKER)

Trademark infringement case regarding Registration No. TMA396,079 (FREEDOMWALKER)

Trademark opposition case regarding Registration No. 1,172,524 (DEMERARA)

Trademark infringement case regarding Registration No. TMA 624,752 (PINK)

Trademark opposition case regarding Application No. 1,206,738 (DEMERARA GOLD)

Trademark expungement case regarding Registration No. TMA528,477 (MYTHOS & Design)

Trade mark opposition case regarding Application No. 1,321,379 (HYUNDAI & Design)

Appeal of a partial summary judgment decision regarding the ownership of Mill-Pac Black

Appeal in a patent impeachment case regarding Patent No. 2,207,045 (Kit and Process for the Manufacture of a Set of Individual Pill Containers)

Interlocutory motion in a patent impeachment case regarding Patent No. 2,207,045 (Kit and Process for the Manufacture of a Set of Individual Pill Containers)

Patent infringement case regarding Patent No. 2,207,045 (Kit and Process for the Manufacture of a Set of Individual Pill Containers)

Trademark opposition case regarding Application No. 898,649 (POPEYE'S SAILORS EXCHANGE)

Trademark opposition case regarding Application No. 801,053 (RED BOOK)

Appeal in a trademark expungement case regarding COUNTRY LIVING.

Appeal in a trademark opposition case regarding XP 2000, XP 2000 MS, XP 2000 AS, XP 2000 V, XP 2000 H, XP 2000 Z, AMERI WAY XT & DESIGN, AMERI XL 4 & DESIGN